Emodin Induced Necroptosis and Inhibited Glycolysis in the Renal Cancer Cells by Enhancing ROS

Renal cell carcinoma (RCC) is a tumor with unpredictable presentation and poor clinical outcome. RCC is always resistant to chemotherapy and radiation, and weakly sensitive to immunotherapeutic agents. Therefore, novel agents and approaches are urgently needed for the treatment of RCC. Emodin, an an...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ke-jie, Meng, Xiang-yu, Chen, Jun-feng, Wang, Kai-yun, Zhou, Cheng, Yu, Rui, Ma, Qi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837784/
https://www.ncbi.nlm.nih.gov/pubmed/33532038
http://dx.doi.org/10.1155/2021/8840590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7837784/
https://www.ncbi.nlm.nih.gov/pubmed/33532038
http://dx.doi.org/10.1155/2021/8840590

Ejemplares similares